Cargando…
Aspirin ameliorates the long‐term adverse effects of doxorubicin through suppression of cellular senescence
A number of childhood cancer survivors develop adverse, late onset side effects of earlier cancer treatments, known as the late effects of cancer therapy. As the number of survivors continues to increase, this growing population is at increased risk for a number of health‐related problems. In the pr...
Autores principales: | Feng, Mingxiao, Kim, Joohwee, Field, Kevin, Reid, Christine, Chatzistamou, Ioulia, Shim, Minsub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996307/ https://www.ncbi.nlm.nih.gov/pubmed/32123852 http://dx.doi.org/10.1096/fba.2019-00041 |
Ejemplares similares
-
Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice
por: Kim, Joohwee, et al.
Publicado: (2016) -
Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells
por: Vaish, Vivek, et al.
Publicado: (2017) -
Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy
por: Naik, Himgauri, et al.
Publicado: (2021) -
Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics
por: Gao, Yueyue, et al.
Publicado: (2023) -
SUN-106 Loss of Coordination in the Expression of Hepatic Lipase and Endoplasmic Reticulum Stress Genes in Steatosis
por: Havighorst, Amanda, et al.
Publicado: (2019)